1. Home
  2. UMH vs IMTX Comparison

UMH vs IMTX Comparison

Compare UMH & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UMH Properties Inc.

UMH

UMH Properties Inc.

SELL

Current Price

$15.29

Market Cap

1.3B

Sector

Real Estate

ML Signal

SELL

IMTX

Immatics N.V.

HOLD

Current Price

$6.75

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
IMTX
Founded
1968
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
UMH
IMTX
Price
$15.29
$6.75
Analyst Decision
Buy
Strong Buy
Analyst Count
9
9
Target Price
★ $18.88
$17.26
AVG Volume (30 Days)
593.2K
★ 855.3K
Earning Date
11-02-2026
11-16-2026
Dividend Yield
★ 5.91%
N/A
EPS Growth
★ 133.33
N/A
EPS
★ 0.08
N/A
Revenue
★ $261,754,000.00
N/A
Revenue This Year
$8.48
N/A
Revenue Next Year
$7.59
N/A
P/E Ratio
$190.38
★ N/A
Revenue Growth
★ 8.81
N/A
52 Week Low
$13.93
$6.73
52 Week High
$16.77
$12.41

Technical Indicators

Market Signals
Indicator
UMH
IMTX
Relative Strength Index (RSI) 45.44 28.56
Support Level $15.13 N/A
Resistance Level $15.79 $10.08
Average True Range (ATR) 0.24 0.42
MACD 0.01 -0.08
Stochastic Oscillator 56.25 3.19

Price Performance

Historical Comparison
UMH
IMTX

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: